Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of TRPM4 ion channel in pediatric arrhythmic syndromes.

World journal of clinical pediatrics·2026
Same author

Missense mutation causes multiple defects in Nav1.4 channel gating and leads to an SCN4A-associated overlap phenotype.

The Journal of general physiology·2026
Same author

Functional characterization of voltage-gated sodium channels in two mirid pests and identification of kdr mutations in pyrethroid resistant Lygus lineolarispopulation.

Insect biochemistry and molecular biology·2026
Same author

How Sodium and Calcium Ions Pass Through Batrachotoxin-Bound Sodium Channel.

Toxins·2025
Same author

Predicting the Damaging Potential of Uncharacterized <i>KCNQ1</i> and <i>KCNE1</i> Variants.

International journal of molecular sciences·2025
Same author

Evolution of iGluR ligand specificity, polyamine regulation, and ion selectivity inferred from a placozoan epsilon receptor.

Communications biology·2025

Related Experiment Video

Updated: Jun 23, 2026

Modeling Ligands into Maps Derived from Electron Cryomicroscopy
09:30

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

Published on: July 19, 2024

Structural model for dihydropyridine binding to L-type calcium channels.

Denis B Tikhonov1, Boris S Zhorov

  • 1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.

The Journal of Biological Chemistry
|May 7, 2009
PubMed
Summary

This study reveals a new model for 1,4-dihydropyridine (DHP) activity at L-type Ca(2+) channels (LTCC). DHP binding stabilizes open channel states, with distinct mechanisms for agonists and antagonists influencing channel function.

More Related Videos

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
07:26

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3

Published on: August 17, 2011

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
08:33

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time

Published on: March 11, 2021

Related Experiment Videos

Last Updated: Jun 23, 2026

Modeling Ligands into Maps Derived from Electron Cryomicroscopy
09:30

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

Published on: July 19, 2024

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
07:26

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3

Published on: August 17, 2011

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
08:33

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time

Published on: March 11, 2021

Area of Science:

  • Molecular Pharmacology
  • Structural Biology
  • Biophysics

Background:

  • 1,4-Dihydropyridines (DHPs) are key ligands for L-type Ca(2+) channels (LTCC).
  • Previous models attributed DHP activity to portside substituents affecting channel gate stability.
  • A novel structural model is proposed to explain DHP agonist and antagonist activities.

Purpose of the Study:

  • To present a new structural model for DHP-LTCC interactions.
  • To elucidate the distinct mechanisms of DHP agonist and antagonist activities.
  • To provide a framework for developing novel LTCC blockers.

Main Methods:

  • Monte Carlo minimizations of DHP-LTCC complexes.
  • Analysis of hydrogen bonding interactions between DHPs and LTCC residues.
  • Structural modeling to predict DHP orientation and substituent effects.

Main Results:

  • DHPs form stabilizing H-bonds with Tyr_IIIS6, Tyr_IVS6, and Gln_IIIS5, common to both agonists and antagonists.
  • These interactions stabilize an open LTCC conformation, increasing channel opening probability.
  • Antagonist portside substituents may destabilize Ca(2+) binding at the selectivity filter, while agonists lack this effect.

Conclusions:

  • DHP activity is determined by interactions at the stern, bow, and starboard, stabilizing open LTCC states.
  • The portside substituent dictates channel closing mechanisms, differentiating agonists from antagonists.
  • This model offers insights for designing new therapeutic LTCC modulators.